Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 247,176	$ 119,629
Accounts receivable, net of allowance for credit losses of $2,400 and $2,584, respectively, and net of allowance for product returns of $1,341 and $1,075, respectively	81,883	76,373
Inventory, net	40,199	34,168
Other current assets, net of allowance for credit losses of $30 and $16, respectively	17,854	13,504
Total current assets	387,112	243,674
Property and equipment, net	42,639	38,548
Intangible assets, net	91,384	103,438
Goodwill	105,662	104,963
Deferred tax assets	20,749	19,137
Operating lease right-of-use assets	33,899	30,523
Other assets, net of allowance for credit losses of $66 and $0, respectively	16,600	17,516
Total assets	698,045	557,799
Current liabilities:
Accounts payable, accrued expenses and other current liabilities	50,029	48,727
Accrued compensation	18,918	16,342
Deferred revenue	4,411	3,043
Operating lease liabilities	9,470	7,683
Total current liabilities	82,828	75,795
Deferred revenue	8,461	7,455
Long-term debt	111,000	63,000
Operating lease liabilities	38,605	37,199
Other liabilities	7,724	7,489
Total liabilities	248,618	190,938
Commitments and contingencies
Redeemable noncontrolling interest	10,711	11,210
Stockholders’ equity
Preferred stock, $0.001 par value, 10,000,000 shares authorized; no shares issued and outstanding as of September 30, 2020 and December 31, 2019	0	0
Common stock, $0.01 par value, 300,000,000 shares authorized; 49,256,397 and 48,700,963 shares issued; and 49,109,244 and 48,700,713 shares outstanding as of September 30, 2020 and December 31, 2019, respectively	493	487
Additional paid-in capital	392,765	365,627
Treasury stock, at cost; 147,153 and 0 shares as of September 30, 2020 and December 31, 2019, respectively	(5,149)	0
Retained earnings / (accumulated deficit)	50,607	(10,463)
Total stockholders’ equity	438,716	355,651
Total liabilities, redeemable noncontrolling interest and stockholders’ equity	$ 698,045	$ 557,799